Synolo Therapeutics is advancing a new class of therapeutics for cancer. Launched by RA Ventures* and leveraging a proprietary discovery platform, we are rapidly building a pipeline of differentiated conditionally-active immunotherapies which promise to be highly effective and safer than the current standard of care.

*RA Ventures is the venture focused division of RA Capital Management.

Synolo Therapeutics

The Cambridge office focuses on advanced scientific research and innovation in biotechnology and life sciences.

Cambridge

Anish Suri

This department focuses on conducting scientific research and development to advance knowledge and innovation.

Research Science

This department focuses on the discovery and development of biologic therapies, including protein science and immunology.

Biologics Discovery

This department oversees and directs research activities to drive innovation and strategic scientific initiatives.

Synolo Therapeutics

Org chart

Teams

Research Science

Biologics Discovery

Research Leadership

Offices

Synolo Therapeutics

Org chart

Teams

Research Science

Biologics Discovery

Research Leadership

Offices

Related companies